{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T10:08:03Z","timestamp":1655806083140},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,9,25]],"date-time":"2014-09-25T00:00:00Z","timestamp":1411603200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1007\/s00262-014-1608-x","type":"journal-article","created":{"date-parts":[[2014,9,24]],"date-time":"2014-09-24T14:56:00Z","timestamp":1411570560000},"page":"15-27","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Novel N-amidinopiperidine-based proteasome inhibitor preserves dendritic cell functionality and rescues their Th1-polarizing capacity in Ramos-conditioned tumor environment"],"prefix":"10.1007","volume":"64","author":[{"given":"Urban","family":"\u0160vajger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Gobec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ale\u0161","family":"Obreza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irena","family":"Mlinari\u010d-Ra\u0161\u010dan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,9,25]]},"reference":[{"issue":"10","key":"1608_CR1","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1034\/j.1600-6143.2002.21006.x","volume":"2","author":"J Wu","year":"2002","unstructured":"Wu J (2002) On the role of proteasomes in cell biology and proteasome inhibition as a novel frontier in the development of immunosuppressants. Am J Transplant 2(10):904\u2013912. doi: 10.1034\/j.1600-6143.2002.21006.x","journal-title":"Am J Transplant"},{"issue":"5","key":"1608_CR2","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nrc1361","volume":"4","author":"J Adams","year":"2004","unstructured":"Adams J (2004) The proteasome: a suitable antineoplastic target. Nat Rev Cancer 4(5):349\u2013360. doi: 10.1038\/nrc1361nrc1361","journal-title":"Nat Rev Cancer"},{"issue":"4\u20135","key":"1608_CR3","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.drup.2008.08.002","volume":"11","author":"DJ McConkey","year":"2008","unstructured":"McConkey DJ, Zhu K (2008) Mechanisms of proteasome inhibitor action and resistance in cancer. Drug Resist Updat 11(4\u20135):164\u2013179. doi: 10.1016\/j.drup.2008.08.002","journal-title":"Drug Resist Updat"},{"issue":"21","key":"1608_CR4","doi-asserted-by":"crossref","first-page":"8120","DOI":"10.1073\/pnas.0401563101","volume":"101","author":"K Sun","year":"2004","unstructured":"Sun K, Welniak LA, Panoskaltsis-Mortari A, O\u2019Shaughnessy MJ, Liu H, Barao I, Riordan W, Sitcheran R, Wysocki C, Serody JS, Blazar BR, Sayers TJ, Murphy WJ (2004) Inhibition of acute graft-versus-host disease with retention of graft-versus-tumor effects by the proteasome inhibitor bortezomib. Proc Natl Acad Sci U S A 101(21):8120\u20138125. doi: 10.1073\/pnas.04015631010401563101","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"1608_CR5","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/j.bbmt.2009.07.016","volume":"15","author":"J Koreth","year":"2009","unstructured":"Koreth J, Alyea EP, Murphy WJ, Welniak LA (2009) Proteasome inhibition and allogeneic hematopoietic stem cell transplantation: a review. Biol Blood Marrow Transplant 15(12):1502\u20131512. doi: 10.1016\/j.bbmt.2009.07.016","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"1608_CR6","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1182\/blood-2005-08-3494","volume":"108","author":"A Nencioni","year":"2006","unstructured":"Nencioni A, Schwarzenberg K, Brauer KM, Schmidt SM, Ballestrero A, Grunebach F, Brossart P (2006) Proteasome inhibitor bortezomib modulates TLR4-induced dendritic cell activation. Blood 108(2):551\u2013558. doi: 10.1182\/blood-2005-08-3494","journal-title":"Blood"},{"issue":"3","key":"1608_CR7","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/eji.200535298","volume":"36","author":"A Nencioni","year":"2006","unstructured":"Nencioni A, Garuti A, Schwarzenberg K, Cirmena G, Dal Bello G, Rocco I, Barbieri E, Brossart P, Patrone F, Ballestrero A (2006) Proteasome inhibitor-induced apoptosis in human monocyte-derived dendritic cells. Eur J Immunol 36(3):681\u2013689. doi: 10.1002\/eji.200535298","journal-title":"Eur J Immunol"},{"key":"1608_CR8","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1146\/annurev.immunol.18.1.767","volume":"18","author":"J Banchereau","year":"2000","unstructured":"Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu YJ, Pulendran B, Palucka K (2000) Immunobiology of dendritic cells. Annu Rev Immunol 18:767\u2013811. doi: 10.1146\/annurev.immunol.18.1.767","journal-title":"Annu Rev Immunol"},{"issue":"12","key":"1608_CR9","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0167-5699(99)01547-9","volume":"20","author":"P Kali\u0144ski","year":"1999","unstructured":"Kali\u0144ski P, Hilkens CMU, Wierenga EA, Kapsenberg ML (1999) T-cell priming by type-1and type-2 polarized dendritic cells: the concept of a third signal. Immunol Today 20(12):561\u2013567. doi: 10.1016\/s0167-5699(99)01547-9","journal-title":"Immunol Today"},{"issue":"12","key":"1608_CR10","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nri1498","volume":"4","author":"D Gabrilovich","year":"2004","unstructured":"Gabrilovich D (2004) Mechanisms and functional significance of tumour-induced dendritic-cell defects. Nat Rev Immunol 4(12):941\u2013952. doi: 10.1038\/nri1498","journal-title":"Nat Rev Immunol"},{"issue":"7","key":"1608_CR11","doi-asserted-by":"crossref","first-page":"e41961","DOI":"10.1371\/journal.pone.0041961","volume":"7","author":"M Gobec","year":"2012","unstructured":"Gobec M, Obreza A, Prijatelj M, Brus B, Gobec S, Mlinaric-Rascan I (2012) Selective cytotoxicity of amidinopiperidine based compounds towards Burkitt\u2019s lymphoma cells involves proteasome inhibition. PLoS ONE 7(7):e41961. doi: 10.1371\/journal.pone.0041961PONE-D-12-05942","journal-title":"PLoS ONE"},{"issue":"3","key":"1608_CR12","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.micinf.2005.10.007","volume":"8","author":"M Hansson","year":"2006","unstructured":"Hansson M, Lundgren A, Elgbratt K, Quiding-J\u00e4rbrink M, Svennerholm A-M, Johansson E-L (2006) Dendritic cells express CCR7 and migrate in response to CCL19 (MIP-3\u03b2) after exposure to Helicobacter pylori. Microbes and Infect 8(3):841\u2013850. doi: 10.1016\/j.micinf.2005.10.007","journal-title":"Microbes and Infect"},{"issue":"4","key":"1608_CR13","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/sj.leu.2402417","volume":"16","author":"JB Almond","year":"2002","unstructured":"Almond JB, Cohen GM (2002) The proteasome: a novel target for cancer chemotherapy. Leukemia 16(4):433\u2013443. doi: 10.1038\/sj.leu.2402417","journal-title":"Leukemia"},{"issue":"6","key":"1608_CR14","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1002\/1097-0215(20001215)88:6<881::AID-IJC7>3.0.CO;2-D","volume":"88","author":"T Frisan","year":"2000","unstructured":"Frisan T, Levitsky V, Masucci MG (2000) Variations in proteasome subunit composition and enzymatic activity in B-lymphoma lines and normal B cells. Int J Cancer 88(6):881\u2013888. doi: 10.1002\/1097-0215(20001215)88:6<881:AID-IJC7>3.0.CO;2-D","journal-title":"Int J Cancer"},{"issue":"2","key":"1608_CR15","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ccr.2007.07.003","volume":"12","author":"JJ Keats","year":"2007","unstructured":"Keats JJ, Fonseca R, Chesi M, Schop R, Baker A, Chng WJ, Van Wier S, Tiedemann R, Shi CX, Sebag M, Braggio E, Henry T, Zhu YX, Fogle H, Price-Troska T, Ahmann G, Mancini C, Brents LA, Kumar S, Greipp P, Dispenzieri A, Bryant B, Mulligan G, Bruhn L, Barrett M, Valdez R, Trent J, Stewart AK, Carpten J, Bergsagel PL (2007) Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma. Cancer Cell 12(2):131\u2013144. doi: 10.1016\/j.ccr.2007.07.003","journal-title":"Cancer Cell"},{"issue":"11","key":"1608_CR16","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1158\/1078-0432.CCR-07-5150","volume":"14","author":"L Wang","year":"2008","unstructured":"Wang L, Kumar S, Fridley BL, Kalari KR, Moon I, Pelleymounter LL, Hildebrandt MA, Batzler A, Eckloff BW, Wieben ED, Greipp PR (2008) Proteasome beta subunit pharmacogenomics: gene resequencing and functional genomics. Clin Cancer Res 14(11):3503\u20133513. doi: 10.1158\/1078-0432.CCR-07-5150","journal-title":"Clin Cancer Res"},{"issue":"21","key":"1608_CR17","doi-asserted-by":"crossref","first-page":"6247","DOI":"10.1158\/1078-0432.CCR-07-1654","volume":"13","author":"BA Teicher","year":"2007","unstructured":"Teicher BA (2007) Transforming growth factor-beta and the immune response to malignant disease. Clin Cancer Res 13(21):6247\u20136251. doi: 10.1158\/1078-0432.CCR-07-1654","journal-title":"Clin Cancer Res"},{"issue":"7","key":"1608_CR18","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1038\/sj.bjc.6601240","volume":"89","author":"A Houston","year":"2003","unstructured":"Houston A, Bennett MW, O\u2019Sullivan GC, Shanahan F, O\u2019Connell J (2003) Fas ligand mediates immune privilege and not inflammation in human colon cancer, irrespective of TGF-beta expression. Br J Cancer 89(7):1345\u20131351. doi: 10.1038\/sj.bjc.66012406601240","journal-title":"Br J Cancer"},{"issue":"10","key":"1608_CR19","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1038\/nm934","volume":"9","author":"C Uyttenhove","year":"2003","unstructured":"Uyttenhove C, Pilotte L, Theate I, Stroobant V, Colau D, Parmentier N, Boon T, Van den Eynde BJ (2003) Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase. Nat Med 9(10):1269\u20131274. doi: 10.1038\/nm934nm934","journal-title":"Nat Med"},{"issue":"5966","key":"1608_CR20","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1126\/science.1178331","volume":"327","author":"F Geissmann","year":"2010","unstructured":"Geissmann F, Manz MG, Jung S, Sieweke MH, Merad M, Ley K (2010) Development of monocytes, macrophages, and dendritic cells. Science 327(5966):656\u2013661. doi: 10.1126\/science.1178331","journal-title":"Science"},{"issue":"10","key":"1608_CR21","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.cellsig.2010.03.018","volume":"22","author":"U \u0160vajger","year":"2010","unstructured":"\u0160vajger U, Anderluh M, Jeras M, Obermajer N (2010) C-type lectin DC-SIGN: an adhesion, signalling and antigen-uptake molecule that guides dendritic cells in immunity. Cell Signal 22(10):1397\u20131405. doi: 10.1016\/j.cellsig.2010.03.018","journal-title":"Cell Signal"},{"issue":"9","key":"1608_CR22","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S1471-4906(02)02281-0","volume":"23","author":"MB Lutz","year":"2002","unstructured":"Lutz MB, Schuler G (2002) Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity? Trends Immunol 23(9):445\u2013449","journal-title":"Trends Immunol"},{"issue":"8","key":"1608_CR23","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/90609","volume":"2","author":"S Akira","year":"2001","unstructured":"Akira S, Takeda K, Kaisho T (2001) Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2(8):675\u2013680. doi: 10.1038\/9060990609","journal-title":"Nat Immunol"},{"issue":"3","key":"1608_CR24","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.smim.2010.03.002","volume":"22","author":"P Kalinski","year":"2010","unstructured":"Kalinski P, Okada H (2010) Polarized dendritic cells as cancer vaccines: directing effector-type T cells to tumors. Semin Immunol 22(3):173\u2013182. doi: 10.1016\/j.smim.2010.03.002","journal-title":"Semin Immunol"},{"issue":"18","key":"1608_CR25","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1101\/gad.1228704","volume":"18","author":"MS Hayden","year":"2004","unstructured":"Hayden MS, Ghosh S (2004) Signaling to NF-kappaB. Genes Dev 18(18):2195\u20132224. doi: 10.1101\/gad.122870418\/18\/2195","journal-title":"Genes Dev"},{"issue":"6673","key":"1608_CR26","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/32588","volume":"392","author":"J Banchereau","year":"1998","unstructured":"Banchereau J, Steinman RM (1998) Dendritic cells and the control of immunity. Nature 392(6673):245\u2013252","journal-title":"Nature"},{"issue":"2","key":"1608_CR27","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3960\/jslrt.51.93","volume":"51","author":"Y Komohara","year":"2011","unstructured":"Komohara Y, Horlad H, Ohnishi K, Ohta K, Makino K, Hondo H, Yamanaka R, Kajiwara K, Saito T, Kuratsu J, Takeya M (2011) M2 macrophage\/microglial cells induce activation of Stat3 in primary central nervous system lymphoma. J Clin Exp Hematop 51(2):93\u201399. doi: 10.3960\/jslrt.51.93","journal-title":"J Clin Exp Hematop"},{"issue":"4","key":"1608_CR28","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/j.1440-1827.2010.02514.x","volume":"60","author":"D Niino","year":"2010","unstructured":"Niino D, Komohara Y, Murayama T, Aoki R, Kimura Y, Hashikawa K, Kiyasu J, Takeuchi M, Suefuji N, Sugita Y, Takeya M, Ohshima K (2010) Ratio of M2 macrophage expression is closely associated with poor prognosis for angioimmunoblastic T-cell lymphoma (AITL). Pathol Int 60(4):278\u2013283. doi: 10.1111\/j.1440-1827.2010.02514.x","journal-title":"Pathol Int"},{"issue":"1","key":"1608_CR29","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/path.2370","volume":"216","author":"Y Komohara","year":"2008","unstructured":"Komohara Y, Ohnishi K, Kuratsu J, Takeya M (2008) Possible involvement of the M2 anti-inflammatory macrophage phenotype in growth of human gliomas. J Pathol 216(1):15\u201324. doi: 10.1002\/path.2370","journal-title":"J Pathol"},{"issue":"6","key":"1608_CR30","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.4049\/jimmunol.168.6.2634","volume":"168","author":"M Relloso","year":"2002","unstructured":"Relloso M, Puig-Kroger A, Pello OM, Rodriguez-Fernandez JL, de la Rosa G, Longo N, Navarro J, Munoz-Fernandez MA, Sanchez-Mateos P, Corbi AL (2002) DC-SIGN (CD209) expression is IL-4 dependent and is negatively regulated by IFN, TGF-beta, and anti-inflammatory agents. J Immunol 168(6):2634\u20132643","journal-title":"J Immunol"},{"issue":"11","key":"1608_CR31","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1093\/intimm\/10.11.1593","volume":"10","author":"A Snijders","year":"1998","unstructured":"Snijders A, Kalinski P, Hilkens CM, Kapsenberg ML (1998) High-level IL-12 production by human dendritic cells requires two signals. Int Immunol 10(11):1593\u20131598","journal-title":"Int Immunol"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-014-1608-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00262-014-1608-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-014-1608-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T12:33:24Z","timestamp":1558701204000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00262-014-1608-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,25]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["1608"],"URL":"https:\/\/doi.org\/10.1007\/s00262-014-1608-x","relation":{},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"value":"0340-7004","type":"print"},{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,25]]}}}